Sustained Improvements with Bimekizumab in Spinal Mobility, Physical Function and Health-Related Quality of Life in Patients with Axial Spondyloarthritis: 2-Year Results from Two Phase 3 Studies

被引：0
|
作者：
Navarro Compan, Victoria [1 ]
Dubreuil, Maureen [2 ]
Gaffney, Karl [3 ]
Kay, Jonathan [4 ,5 ]
de la Loge, Christine [6 ]
Massow, Ute [7 ]
Taieb, Vanessa [8 ]
Vaux, Thomas [9 ]
Deodhar, Atul [10 ]
机构：
[1] La Paz Univ Hosp, Hosp La Paz Inst Hlth Res IdiPAZ, Madrid, Spain
[2] Boston Univ, Sch Med, Sect Rheumatol, Boston, MA 02118 USA
[3] Hlth Care NHS, Norwich, Norfolk, England
[4] UMass Chan Med Sch, Div Rheumatol, Dept Med, Worcester, MA USA
[5] UMass Mem Med Ctr, Worcester, MA USA
[6] UCB Pharma, Brussels, Belgium
[7] UCB Pharma, Monheim, Germany
[8] UCB Pharma, Colombes, France
[9] UCB Pharma, Slough, Berks, England
[10] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1480
引用
收藏
页码：3015 / 3018
页数：4
相关论文
共 50 条
  • [1] BIMEKIZUMAB IMPROVED PHYSICAL FUNCTION AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES
    Nicholls, David
    Dubreuil, Maureen
    Gaffney, Karl
    Gensler, Lianne S.
    Kay, Jonathan
    Navarro-Compan, Victoria
    de la Loge, Christine
    Ellis, Alicia
    Fleurinck, Carmen
    Oortgiesen, Marga
    Taieb, Vanessa
    Deodhar, Atul
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 26 - 27
  • [2] Bimekizumab Improves Physical Function and Health-Related Quality of Life in Patients with Axial Spondyloarthritis: Results from Two Phase 3 Studies
    Dubreuil, Maureen
    Gaffney, Karl
    Gensler, Lianne
    Kay, Jonathan
    Navarro-Compan, Victoria
    de la Loge, Christine
    Ellis, Alicia
    Fleurinck, Carmen
    Oortgiesen, Marga
    Taieb, Vanessa
    Deodhar, Atul
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 820 - 823
  • [3] Sustained improvements with bimekizumab in patientreported symptoms of axial spondyloarthritis: 2-year results from two phase 3 studies
    Marzo-Ortega, H.
    Mease, P. J.
    Dougados, M.
    Dubreuil, M.
    Magrey, M.
    Rudwaleit, M.
    D'Agostino, M. A.
    de la Loge, C.
    Fleurinck, C.
    Massow, U.
    Taieb, V
    Deodhar, A.
    SWISS MEDICAL WEEKLY, 2024, 154 : 34S - 34S
  • [4] Bimekizumab Improved Physical Function and Health-Related Quality of Life in Patients with Axial Spondyloarthritis: 52-Week Results from Two Phase 3 Studies
    Dubreuil, Maureen
    Gaffney, Karl
    Kay, Jonathan
    Navarro-Compan, Victoria
    de la Loge, Christine
    Ellis, Alicia
    Fleurinck, Carmen
    Massow, Ute
    Taieb, Vanessa
    Deodhar, Atul
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1032 - 1035
  • [5] Sustained Improvements with Bimekizumab in Patient-Reported Symptoms of Axial Spondyloarthritis: 2-Year Results from Two Phase 3 Studies
    Marzo-Ortega, Helena
    Mease, Philip
    Dougados, Maxime
    Dubreuil, Maureen
    Magrey, Marina
    Rudwaleit, Martin
    D'Agostino, Maria Antonietta
    de la Loge, Christine
    Massow, Ute
    Taieb, Vanessa
    Voiniciuc, Diana
    Deodhar, Atul
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1209 - 1213
  • [6] Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: results from two phase 3 studies
    Dubreuil, Maureen
    Navarro-Compan, Victoria
    Boonen, Annelies
    Gaffney, Karl
    Gensler, Lianne S.
    de la Loge, Christine
    Vaux, Thomas
    Fleurinck, Carmen
    Massow, Ute
    Taieb, Vanessa
    Morup, Michael F.
    Deodhar, Atul
    Rudwaleit, Martin
    RMD OPEN, 2024, 10 (02):
  • [7] Long-term safety and efficacy of bimekizumab in axial spondyloarthritis: 2-year results from two phase 3 studies
    Baraliakos, Xenofon
    Deodhar, Atul
    van der Heijde, Desiree
    van den Bosch, Filip
    Magrey, Marina
    Maksymowych, Walter P.
    Tomita, Tetsuya
    Xu, Huji
    Massow, Ute
    Vaux, Tom
    Prajapati, Chetan
    Manente, Myriam
    Marten, Alexander
    Gensler, Lianne S.
    RHEUMATOLOGY, 2025,
  • [8] LONG-TERM SUSTAINED EFFICACY AND SAFETY OF BIMEKIZUMAB ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
    Baraliakos, X.
    Deodhar, A.
    van der Heijde, D.
    van den Bosch, F.
    Magrey, M.
    Maksymowych, W. P.
    Tomita, T.
    Xu, H.
    Massow, U.
    Fleurinck, C.
    Vaux, T.
    Prajapati, C.
    Shepherd-Smith, J.
    Marten, A.
    Gensler, L. S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 93 - 94
  • [9] BIMEKIZUMAB DEMONSTRATES SUSTAINED IMPROVEMENT IN QUALITY OF LIFE UP TO WEEK 52 IN PATIENTS ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES
    McKay, Neil D.
    Bennett, Alexander
    Goodson, Nicola
    Fleurinck, Carmen
    de la Loge, Christine
    Massow, Ute
    Taieb, Vanessa
    Marzo-Ortega, Helena
    Gaffney, Karl
    RHEUMATOLOGY, 2024, 63 : I157 - I158
  • [10] Bimekizumab demonstrates sustained improvement in quality of life up to week 52 in patients across the full spectrum of axial spondyloarthritis: results from two phase 3 studies
    McKay, Neil D.
    Bennett, Alexander
    Goodson, Nicola
    Fleurinck, Carmen
    de la Loge, Christine
    Massow, Ute
    Taieb, Vanessa
    Marzo-Ortega, Helena
    Gaffney, Karl
    RHEUMATOLOGY, 2024, 63
12345